Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, expectations were $2.98. Operator: Good morning and thank you for standing by.

A review of key developments and emerging issues in US International Trade Commission (ITC or Commission) unfair import ...

On January 14, 2025, the United States Court of Appeals for the Federal Circuit issued a precedential decision in Lynk Labs, ...

Anderson’s Paramount Theatre is renovating a building behind the historic theater space, and incorporating it into its ...

AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...

Since our last Ball State Update, the United States has elected a new president and Indiana has elected a new governor.  Both ...

He emphasized the consistent outperformance of the ex-Humira platform, which grew over 18% annually and accelerated to 22% growth in Q4. The company projects mid-single-digit revenue growth in 2025, ...

"Last week the Federal Circuit Court of Appeals in Lynk Labs v. Samsung, decided a prior art issue in one of the thornier ...

While reporting financial results for the fourth quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) initiated its ...

The company’s 2025 adjusted diluted EPS guidance excludes any impact from acquired IPR&D and milestones that may be incurred during 2025, ...

Dewatering pump and dredging specialist IPR (Integrated Pump Rental) has extended its rapid-response dewatering services into ...

SastaSundar Ventures, which operates health-focussed digital platforms, has said that its partnership with ecommerce giant ...